Loss of P53 Function Activates JAK2–STAT3 Signaling to Promote Pancreatic Tumor Growth, Stroma Modification, and Gemcitabine Resistance in Mice and Is Associated With Patient Survival-Reference-Cited by-同舟云学术

Loss of P53 Function Activates JAK2–STAT3 Signaling to Promote Pancreatic Tumor Growth, Stroma Modification, and Gemcitabine Resistance in Mice and Is Associated With Patient Survival

Published:2016-07 Issue:1 Volume:151 Page:180-193.e12
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Wörmann Sonja M.,Song Liang,Ai Jiaoyu,Diakopoulos Kalliope N.,Kurkowski Magdalena U.,Görgülü Kivanc,Ruess Dietrich,Campbell Andrew^ORCID,Doglioni Claudio,Jodrell Duncan,Neesse Albrecht,Demir Ihsan E.,Karpathaki Angelica-Phaedra,Barenboim Maxim,Hagemann Thorsten,Rose-John Stefan,Sansom Owen^ORCID,Schmid Roland M.,Protti Maria P.,Lesina Marina,Algül Hana

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference45 articles.

1. Pancreatic cancer;Hidalgo;N Engl J Med,2010

2. STAT3 plays a critical role in KRAS-induced pancreatic tumorigenesis;Corcoran;Cancer Res,2011

3. Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling;Jones;J Clin Invest,2011

4. Stat3/Socs3 activation by IL-6 transsignaling promotes progression of pancreatic intraepithelial neoplasia and development of pancreatic cancer;Lesina;Cancer Cell,2011

5. STATs in cancer inflammation and immunity: a leading role for STAT3;Yu;Nat Rev Cancer,2009

Cited by 223 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MiR-618 suppresses the proliferation, invasion, and migration of non-small lung cancer via the JAK2/STAT3 axis;2024-08-09

2. Insights into gemcitabine resistance in pancreatic cancer: association with metabolic reprogramming and TP53 pathogenicity in patient derived xenografts;Journal of Translational Medicine;2024-08-05

3. Mutant TP53 switches therapeutic vulnerability during gastric cancer progression within interleukin-6 family cytokines;Cell Reports;2024-08

4. p53 at the crossroads of tumor immunity;Nature Cancer;2024-07-15

5. MLIP and Its Potential Influence on Key Oncogenic Pathways;Cells;2024-06-26